Nasdaq
ABUS
Arbutus Biopharma Corporation
- Health Care
- Canada
- 1 day
- −1.7%
- 1 month
- −12.4%
- 1 year
- +30.8%
$4.54 · Mkt cap $897M
At the 6 Aug 2026 close
Nasdaq
Arbutus Biopharma Corporation
$4.54 · Mkt cap $897M
At the 6 Aug 2026 close
Arbutus Biopharma Corporation trades under the ticker ABUS on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its market capitalisation is $897M. The last closing price was $4.54, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +30.8%, and −12.4% over the past month. Returns are price returns and exclude dividends.
This page exists because ABUS is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.